Activity Summary:
To further expand knowledge from From Diagnosis to Discontinuation: Rethinking the IPF Patient Experience, presented by Dr. Kevin R. Flaherty, HCPs can access a downloadable resources designed to reinforce and enhance information that can be utilized directly in clinical settings or for further study and reference.

Clinical Slide Deck
Downloadable PDF of presentation slides, including data visuals, algorithms, and expert insights - ideal for review, teaching, or clinical discussions.

Expert Commentary Transcript
A downloadable transcript of the podcast/video for learners who prefer text-based review or need an offline resource.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
Join internationally recognized ILD experts Steven D. Nathan, MD, Kevin R. Flaherty, MD, and Ayodeji Adegunsoye, MD, MS, as they explore the latest advances transforming the diagnosis and management of fibrotic interstitial lung diseases (ILDs).

This interactive symposium combines expert insights, real-world cases, and live audience polling to help clinicians diagnose ILD earlier, recognize disease progression, optimize antifibrotic therapy, and apply emerging evidence to personalize patient care. Leave with practical strategies you can implement immediately to improve outcomes for patients with fibrotic ILD.care.

Can't attend in-person? We have a virtual option available!

Activity Summary:
Idiopathic pulmonary fibrosis (IPF) presents ongoing challenges across the patient journey, from timely diagnosis to long-term disease management. Nonspecific symptoms often delays appropriate imaging and referral, while issues related to antifibrotic tolerability and treatment discontinuation may further complicate care. Clinicians must also consider changes in physiologic measures, including DLco, alongside emerging understanding of pulmonary vascular involvement and evolving therapeutic approaches.

In this podcast, Dr. Kevin Flaherty shares expert perspectives and case-based insights on recognizing IPF earlier, optimizing antifibrotic therapy, proactively addressing adverse events, and interpreting key diagnostic and prognostic indicators. Listen in to explore strategies that can help inform timely diagnosis, individualized treatment decisions, and ongoing care for patients living with IPF.

Activity Summary:
Idiopathic pulmonary fibrosis (IPF) remains challenging to diagnose and manage in routine clinical practice. Nonspecific symptoms often delay HRCT imaging and referral, while real-world barriers such as antifibrotic tolerability and early discontinuation complicate long-term management. Clinicians must also interpret physiologic trends, including DLco decline, and integrate evolving insights into pulmonary vascular involvement and emerging therapies.

Throughout this video, Dr. Kevin Flaherty provides practical, case-based strategies to strengthen early recognition, optimize antifibrotic use, manage adverse events proactively, and interpret key diagnostic and prognostic markers. Through clinical scenarios and expert perspectives, participants will gain actionable tools to support earlier diagnosis, more personalized treatment decisions, and sustained care for patients with IPF.

Activity Summary:
To further expand knowledge from the Talking HLH: Practical Insights for Diagnosing and Managing Adult HLH, presented by Drs. Sarah Nikiforow and Daniella Schwartz, HCPs can access a variety of downloadable resources designed to reinforce and enhance information that can be utilized directly in clinical settings or for further study and reference.

Adult HLH Diagnostic and Management Algorithm
A visually structured, step-by-step clinical algorithm outlining the recommended approach to evaluating and managing suspected adult HLH.

Adult HLH Recognition and Diagnostic Quick-Reference Guide
A concise clinical reference tool summarizing early warning signs, key laboratory markers, and recommended first-line investigations for suspected adult HLH.

Clinical Slide Kit
Downloadable PDF of presentation slides, including data visuals, algorithms, and expert insights - ideal for review, teaching, or clinical discussions.

Expert Commentary Transcript
A downloadable transcript of the podcast/video for learners who prefer text-based review or need an offline resource.

Guideline & References
Links to key clinical guidelines, landmark publications, diagnostic frameworks, and educational resources related to adult HLH and hyperinflammatory syndromes

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational podcasts will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of "what you need to know" episodes from data presented at AIDS 2026

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational Clinical Clips will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of "what you need to know" videos from data presented at AIDS 2026

Activity Summary:
Adult HLH is increasingly recognized as part of a broader hyperinflammatory spectrum, yet early diagnosis and management remain challenging in clinical practice. Because many adults present with nonspecific symptoms that overlap with sepsis, malignancy-associated inflammation, or autoimmune disease, timely recognition and treatment can be difficult.

This four-episode podcast series explores the full spectrum of adult HLH, from raising diagnostic suspicion to implementing contemporary treatment strategies. Through expert discussion and real-world clinical insights, Dr. Sarah Nikiforow and Dr. Daniella Schwartz aim to strengthen the ability to recognize HLH across diverse clinical settings, integrate biomarkers and prognostic indicators into clinical decision-making, and apply adult-specific management strategies, including emerging therapeutic options.

Activity Summary:
Adult HLH is increasingly recognized as part of a broader hyperinflammatory spectrum, yet early identification and management remain challenging in routine clinical practice. Many adult patients present with nonspecific symptoms that overlap with sepsis, malignancy-associated inflammation, or autoimmune disease, which can delay recognition and treatment.

In this series, Drs. Sarah Nikiforow and Daniella Schwartz explore the full spectrum of adult HLH, from diagnostic suspicion to modern treatment approaches. Through four episodes, this activity aims to strengthen the ability to recognize HLH across diverse clinical settings, integrate biomarkers and prognostic indicators into clinical decision-making, and apply adult-specific management strategies, including emerging therapeutic options.

Activity Summary:
To further expand knowledge from the What's New Doc? From Data to Decisions: Advancing IPF Care in 2026 presented by Dr. Steven Nathan, HCPs can access downloadable resources designed to reinforce and enhance information that can be utilized directly in clinical settings or for further study and reference.

Available Resources:

Clinical Snippet Highlights
Concise, one-page summaries of key IPF studies featured in this activity, offering quick, actionable insights to support day-to-day clinical decision-making.

Downloadable Slides
Downloadable PDF of presentation slides, including data visuals, algorithms, and expert insights - ideal for review, teaching, or clinical discussions.

Expert Commentary Transcript
A downloadable transcript of the podcast/video for learners who prefer text-based review or need an offline resource.

These resources are not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
To further expand knowledge from the Relapsed/Refractory Multiple Myeloma in Real Time: Practical Insights for the First Relapse, presented by Drs. Ajai Chari and Sagar Lonial, HCPs can access a variety of downloadable resources designed to reinforce and enhance information that can be utilized directly in clinical settings or for further study and reference.

Clinical Slide Kit
Downloadable PDF of presentation slides, including data visuals, algorithms, and expert insights - ideal for review, teaching, or clinical discussions.

Expert Commentary Transcripts
A downloadable transcript of the podcast/video for learners who prefer text-based review or need an offline resource.

Reference and Resources
Direct access to featured studies, abstracts, and other kit materials cited in the program.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
Advances in idiopathic pulmonary fibrosis (IPF) research continue to provide new insights into disease biology, treatment strategies, and the evolving evidence landscape. Yet, translating emerging data into clinical practice remains a challenge for many healthcare professionals.

In this podcast episode, Dr. Steven Nathan discusses the latest clinical trial findings, real-world evidence, and scientific developments shaping the current understanding of IPF. Through expert analysis and practical discussion, he explores the implications of these advances for disease management, treatment decision-making, and the future of IPF care in 2026.

Activity Summary:
Recent advances in idiopathic pulmonary fibrosis (IPF) continue to expand the evidence base, offering important insights into disease biology, therapeutic strategies, and ongoing research. However, clinicians often face challenges in interpreting and applying these insights within the context of evolving IPF care.

In this What's New Doc video, Dr. Steven Nathan reviews the latest clinical trial findings, real-world evidence, and scientific advances shaping the evolving understanding of IPF. By translating emerging data into practical clinical insights, he discusses their impact on disease management, treatment decisions, and the future direction of IPF care in 2026.

Activity Summary:
Continue exploring a collection of downloadable resources designed to support learning and clinical application from our recent activity, Conversations in HIV: Fulfilling Individual Choices to Optimize PrEP Uptake-Persistence.

Available Resources:

Downloadable Slides
Review presentation slides with key data, visuals, and clinical insights.

Podcast Transcript
Download the transcript for convenient text-based review anytime.

These resources are not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
Managing relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As therapeutic options continue to expand and clinical guidance evolves, healthcare professionals must navigate challenges related to risk stratification, treatment selection, sequencing strategies, and the integration of emerging immunotherapies into practice.

Clinicians may also face uncertainty in distinguishing mechanisms of action, managing immune-related toxicities, and selecting appropriate therapies in the context of treatment resistance. Additionally, real-world barriers such as staffing shortages, infusion capacity constraints, and workflow demands can complicate the implementation of optimal care. This podcast series features expert-led conversations that deliver practical insights and real-world strategies to support confident, guideline-informed decision-making in the management of RRMM.

Activity Summary:
This expert-led roundtable explores HIV prevention through the lens of real patient cases. They examine diverse scenarios, highlighting challenges and successes in implementing prevention methods such as pre-exposure prophylaxis (PrEP), safer sex practices, and regular testing.

Through in-depth discussion of these cases, the group identifies barriers to prevention, cultural and social factors influencing patient behavior, and effective communication strategies. These sessions aim to foster practical insights and improve patient-centered approaches to reduce new HIV infections in diverse populations.

Join us to engage in meaningful dialogue and translate case-based learning into impactful prevention efforts.

Activity Summary:
Relapsed/refractory multiple myeloma (RRMM) remains a complex and rapidly evolving disease state, particularly at first relapse, when timely, evidence-based decisions regarding risk stratification, treatment selection, and sequencing are essential. Healthcare professionals often face challenges keeping pace with expanding therapeutic options, emerging immunotherapies, and evolving clinical guidelines.

Many clinicians report uncertainty in differentiating mechanisms of action, managing immune-related toxicities, and optimizing treatment sequencing in the setting of emerging resistance. In addition, community and mixed-practice settings may encounter practical barriers, including staffing constraints, infusion capacity limitations, and workflow integration challenges. This mini-module series features expert-led discussions focused on practical implementation strategies to support confident, guideline-aligned decision-making and effective real-world application in RRMM care.

Activity Summary:
This expert-led roundtable explores HIV prevention through the lens of real patient cases. They examine diverse scenarios, highlighting challenges and successes in implementing prevention methods such as pre-exposure prophylaxis (PrEP), safer sex practices, and regular testing.

Through in-depth discussion of these cases, the group identifies barriers to prevention, cultural and social factors influencing patient behavior, and effective communication strategies. These sessions aim to foster practical insights and improve patient-centered approaches to reduce new HIV infections in diverse populations.

Join us to engage in meaningful dialogue and translate case-based learning into impactful prevention efforts.

Activity Summary:
Continue exploring a collection of downloadable resources designed to support learning and clinical application from our recent activity, From Refractory to Resolved: Rethinking Uncontrolled Gout in 2026 with Dr. Robert Terkeltaub.

Available Resources:

Downloadable Slides
Review presentation slides with key data, visuals, and clinical insights.

Podcast Transcript
Download the transcript for convenient text-based review anytime.

References & Resources
A list of key studies, abstracts, and materials featured in the activity.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
Managing uncontrolled gout isn’t always straightforward—especially when flares persist, comorbidities complicate care, or standard therapies fall short. As our understanding of gout expands beyond just elevated uric acid, clinicians are being asked to think differently, integrating immune pathways, real-world evidence, and emerging treatments into everyday practice.

From Refractory to Resolved: Rethinking Uncontrolled Gout in 2026, this CME-accredited podcast explores how to approach these complex cases with greater clarity and confidence. Featuring expert insights and the latest clinical evidence, each episode dives into practical strategies across the continuum of gout care.

Listeners will hear discussions on advances in uricase-based therapies, selective URAT1 inhibitors, and inflammation-targeted treatments, along with key considerations around safety, sequencing, and collaborative care. Through real-world examples and focused conversations, this series equips clinicians with actionable tools to personalize treatment, address therapeutic challenges, and improve long-term outcomes for patients living with uncontrolled gout.

Activity Summary:
To further build on the insights presented in the Clinical Clips® from EASL Congress 2026: Key Breakthroughs in the Treatment of PBC by Dr. Kris Kowdley, HCPs can access a range of downloadable resources designed to reinforce key concepts and support practical application in clinical care.

Available Resources:

Downloadable Slide Deck (PDF)
Downloadable version of the presentation slides used by the faculty, including data visuals, figures, and key discussion points.

Expert Commentary Transcript
A transcript of the podcast version of the program, reflecting the expert discussion and interpretation of EASL 2026 data.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
These podcast episodes explore the rapidly evolving treatment landscape of Primary Biliary Cholangitis, highlighting recent therapeutic advances and reviews emerging clinical evidence on promising investigational therapies.

Designed for healthcare professionals, these episodes provides expert commentary on the latest cutting-edge data presented at EASL Congress 2026. Through an engaging podcast format, listeners will gain practical insights into how new evidence can inform personalized treatment strategies, support improved patient outcomes, and enhance the overall quality of care for people living with PBC.

Activity Summary:
Managing uncontrolled gout can be challenging, especially when patients continue to flare, struggle with comorbidities, or fail to respond as expected to standard therapy. As the understanding of gout evolves beyond hyperuricemia alone, clinicians are increasingly called upon to integrate immune mechanisms, real-world evidence, and new treatment options into everyday decision-making. Staying current requires not only awareness of emerging data, but also clarity on how to apply it in complex, real-world patients.

From Refractory to Resolved: Rethinking Uncontrolled Gout in 2026 is a CME-accredited educational program designed to help clinicians navigate these challenges with confidence. This program brings together expert perspectives, recent clinical evidence, and practical insights across the continuum of gout care. Learners will explore advances in uricase-based therapies, selective URAT1 inhibitors, and inflammation-targeted approaches, while also addressing safety, sequencing, and multidisciplinary coordination. Through focused discussion and clinically relevant examples, participants will gain actionable strategies to personalize care, overcome treatment inertia, and improve long-term management for patients living with uncontrolled gout.

Activity Summary:
These videos provide a concise overview of the latest clinical developments in Primary Biliary Cholangitis presented at EASL Congress 2026. Expert faculty discuss emerging evidence that is shaping the evolving treatment landscape and what these updates may mean for clinical practice.

Watch to gain practical insights into applying the newest data to personalized patient management, with the goal of improving outcomes and advancing the quality of care for individuals living with PBC.